filmov
tv
Second Annual “Living with EGFR-Mutant Lung Cancer: A Virtual Forum for Patients and Caregivers”
Показать описание
During this event we will discuss information about EGFR-mutant lung cancer, research advances, symptom management, as well as hearing from our patients and caregivers.
Second Annual “Living with EGFR-Mutant Lung Cancer: A Virtual Forum for Patients and Caregivers”
Q & A with EGFR-Mutant Lung Cancer Experts | 2024 Living with EGFR-Mutant Lung Cancer Patient Fo...
Patient and Caregiver Panel | 2024 Living with EGFR-Mutant Lung Cancer Patient Forum
EGFR-Mutant Lung Cancer & Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient F...
Patient and Caregiver Panel | 2023 Living with EGFR-Mutant Lung Cancer Patient Forum
Q & A with EGFR-Mutant Lung Cancer Experts | 2023 Living with EGFR-Mutant Lung Cancer Patient Fo...
Symptom Management | 2024 Living with EGFR-Mutant Lung Cancer Patient Forum
2021 Living with EGFR-Mutant Lung Cancer: A Virtual Forum for Patients and Caregivers
Supportive Care Team Panel | 2023 Living with EGFR-Mutant Lung Cancer Patient Forum
One-to-One Program | 2023 Living with EGFR-Mutant Lung Cancer Patient Forum
Symptom Management | 2023 Living with EGFR-Mutant Lung Cancer Patient Forum
Treatment Updates: EGFR-Mutant Lung Cancer | 2024 Living with EGFR-Mutant Lung Cancer Patient Forum
Integrative Therapy and Resources | 2023 Living with EGFR-Mutant Lung Cancer Patient Forum
Empowering EGFR-Mutant Lung Cancer Patients to Live Their Best Life
EGFR-Mutant Lung Cancer: A Patient's Journey
Brain Metastases in EGFR-Mutant Lung Cancer | 2023 Living with EGFR-Mutant Lung Cancer Patient Forum
Future Research and Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient Forum
15 Years of Advances in EGFR Mutant Lung Cancer
Genetics and Genomics | 2024 Living with EGFR-Mutant Lung Cancer Patient Forum
Oligoprogressive Non-Small Cell Lung Cancer | 2024 Living with EGFR-Mutant Lung Cancer Patient Forum
Emerging Data in EGFR-Mutant Lung Cancer
Molecular testing in EGFR mutant driven NSCLC
EGFR Mutations in Patients With Lung Cancer
Atezolizumab with erlotinib in combination treatment for EGFR mutant NSCLC
Комментарии